6.2 Long-term follow-up of right atrial ablation in atrial fibrillation

EP Europace ◽  
2003 ◽  
Vol 4 ◽  
pp. A9
Author(s):  
L CALO
Keyword(s):  
Atrial Fibrillation ◽  
Right Atrial ◽  
Atrial Ablation ◽  
Long Term Follow Up

scholarly journals A35-4 Long-term follow-up of right atrial ablation in patients with atrial fibrillation: Efficacy and impact on quality of life

EP Europace ◽  
2003 ◽  
Vol 4 (Supplement_2) ◽  
pp. B54-B54
Author(s):  
L. Calo ◽  
F. Lamberti ◽  
M.L. Loricchio ◽  
A. Castro ◽  
C. Pandozi ◽  
...  
Keyword(s):  
Quality Of Life ◽  
Atrial Fibrillation ◽  
Right Atrial ◽  
Atrial Ablation ◽  
Long Term Follow Up

scholarly journals 6.2 Long-term follow-up of right atrial ablation in atrial fibrillation

EP Europace ◽  
2003 ◽  
Vol 4 ◽  
pp. A9-A10
Author(s):  
L Calò
Keyword(s):  
Atrial Fibrillation ◽  
Right Atrial ◽  
Atrial Ablation ◽  
Long Term Follow Up

Long-Term Follow-Up of Right Atrial Ablation in Patients with Atrial Fibrillation:

2004 ◽  
Vol 15 (1) ◽  
pp. 37-43 ◽  
Author(s):  
LEONARDO CALÒ ◽  
FILIPPO LAMBERTI ◽  
MARIA LUISA LORICCHIO ◽  
ANTONIO CASTRO ◽  
SHLOMO SHPUN ◽  
...  
Keyword(s):  
Atrial Fibrillation ◽  
Right Atrial ◽  
Atrial Ablation ◽  
Long Term Follow Up

scholarly journals 6.2 Long-term follow-up of right atrial ablation in atrial fibrillation

EP Europace ◽  
2003 ◽  
Vol 4 (Supplement_1) ◽  
pp. A9-A10
Author(s):  
L. Calò ◽  
F. Lamberti ◽  
M.L. Loricchio ◽  
A. Castro ◽  
C. Pandozi ◽  
...  
Keyword(s):  
Atrial Fibrillation ◽  
Right Atrial ◽  
Atrial Ablation ◽  
Long Term Follow Up

Long-Term Follow-Up After Right Atrial Radiofrequency Catheter Treatment of Paroxysmal Atrial Fibrillation

1998 ◽  
Vol 21 (11) ◽  
pp. 2533-2538 ◽  
Author(s):  
PIERRE JAIS ◽  
DIPEN C. SHAH ◽  
ATSUSHI TAKAHASHI ◽  
MELEZE HOCINI ◽  
MICHEL HAISSAGUERRE ◽  
...  
Keyword(s):  
Atrial Fibrillation ◽  
Paroxysmal Atrial Fibrillation ◽  
Right Atrial ◽  
Long Term Follow Up

Atrial fibrillation associated with increased risk of venous thromboembolism

2015 ◽  
Vol 113 (01) ◽  
pp. 185-192 ◽  
Author(s):  
Chun-Cheng Wang ◽  
Cheng-Li Lin ◽  
Guei-Jane Wang ◽  
Chiz-Tzung Chang ◽  
Fung-Chang Sung ◽  
...  
Keyword(s):  
Atrial Fibrillation ◽  
Venous Thromboembolism ◽  
Incidence Rates ◽  
Vein Thrombosis ◽  
Kaplan Meier ◽  
Increased Risk ◽  
Long Term Follow Up ◽  
Deep Vein

SummaryWhether atrial fibrillation (AF) is associated with an increased risk of venous thromboembolism (VTE) remains controversial. From Longitudinal Health Insurance Database 2000 (LHID2000), we identified 11,458 patients newly diagnosed with AF. The comparison group comprised 45,637 patients without AF. Both cohorts were followed up to measure the incidence of deep-vein thrombosis (DVT) and pulmonary embolism (PE). Univariable and multivariable competing-risks regression model and Kaplan-Meier analyses with the use of Aelon-Johansen estimator were used to measure the differences of cumulative incidences of DVT and PE, respectively. The overall incidence rates (per 1,000 person-years) of DVT and PE between the AF group and non-AF groups were 2.69 vs 1.12 (crude hazard ratio [HR] = 1.92; 95 % confidence interval [CI] = 1.54-2.39), 1.55 vs 0.46 (crude HR = 2.68; 95 % CI = 1.97-3.64), respectively. The baseline demographics indicated that the members of the AF group demonstrated a significantly older age and higher proportions of comorbidities than non-AF group. After adjusting for age, sex, and comorbidities, the risks of DVT and PE remained significantly elevated in the AF group compared with the non-AF group (adjusted HR = 1.74; 95 %CI = 1.36-2.24, adjusted HR = 2.18; 95 %CI = 1.51-3.15, respectively). The Kaplan-Meier curve with the use of Aelon-Johansen estimator indicated that the cumulative incidences of DVT and PE were both more significantly elevated in the AF group than in the non-AF group after a long-term follow-up period (p<0.01). In conclusion, the presence of AF is associated with increased risk of VTE after a long-term follow-up period.

scholarly journals Long term follow-up of a right side only approach for ablation of atrial fibrillation

1998 ◽  
Vol 31 ◽  
pp. 512
Author(s):  
A. Natale ◽  
E. Pisano ◽  
R. Fanolli ◽  
G. Tomassoni ◽  
A. Wolverton ◽  
...  
Keyword(s):  
Atrial Fibrillation ◽  
Long Term Follow Up

Abstract 18649: Long-term Outcome and the Mechanisms of Pulmonary Antrum Radial-linear Ablation in Patients With Paroxysmal Atrial Fibrillation

Circulation ◽  
2015 ◽  
Vol 132 (suppl_3) ◽  
Author(s):  
Xue Zhao ◽  
Jianqiang Hu ◽  
Yan Huang ◽  
Yawei Xu ◽  
Yanzhou Zhang ◽  
...  
Keyword(s):  
Atrial Fibrillation ◽  
Paroxysmal Atrial Fibrillation ◽  
Holter Monitoring ◽  
Pericardial Tamponade ◽  
Term Outcome ◽  
Long Term Outcome ◽  
Long Term Follow Up ◽  
One Year

Objectives: The aim of this study was to determine the mechanisms and effectiveness of pulmonary antrum radial-linear (PAR) ablation in comparison with pulmonary vein isolation (PVI) in patients with paroxysmal atrial fibrillation (AF) after a long-term follow-up. Background: The one-year follow up data suggested that PAR ablation appeared to have a better outcome over the conventional PVI for paroxysmal AF. Methods: The enrollment occurred between March, 2011, and August, 2011, with the last follow-up in May, 2014. A total of 133 patients with documented paroxysmal AF were enrolled from 5 centers and randomized to PAR group or PVI group. Event ECG recorder and Holter monitoring were conductedduring the follow-up for all patients. Results: The average procedure time was 151±23 min in PAR group and 178±43 min in PVI group ( P <0.001). The average fluoroscopy time was 21±7 min in PAR group and 27±11 min in PVI group ( P= 0.002). AF triggering foci were eliminated in 59 patients (89.4%) in PAR group, whereas, only 4 patients (6.0%) in PVI group (P<0.001).At median 36 (37-35) months of follow-up after single ablation procedure, 43 of 66 patients in PAR group (65%) and 28 of 67 patients in PVI group (42%) had no recurrence of AF off antiarrhythmic drug (AAD) (P=0.007); and 47 of 66 patients in PAR group (71%) and 32 of 67 patients in PVI group (48%) had no recurrence of AF with AAD (P=0.006). At the last follow-up, the burden of AF was significantly lower in PAR group than in PVI group (0.9% ± 2.3% vs 4.9% ± 9.9%;90th percentile, 5.5% vs 19.6%; P=0.008). No major adverse event (death, stroke, PV stenosis) was observed in all the patients except one case of pericardial tamponade. Conclusions: PAR ablation is a simple, safe, and effective strategy for the treatment of paroxysmal AF with better long-term outcome than PVI. PAR ablation might exhibit the beneficial effect on AF management through multiple mechanisms. Registration: ChiCTR-TRC-11001191

Sign in / Sign up

Export Citation Format

Share Document